AstraZeneca has filed a lawsuit against Indian major Ranbaxy Laboratories in the district court of New Jersey, US, alleging "wilful infringement" of its patent for esomeprazole magnesium, marketed......
Drug maker Ranbaxy’s troubles with the US Food and Drug Administration (FDA) continue, with the American regulator allowing Israel-based Teva Pharma to launch the generic of Nexium, a......
FDA had cancelled Ranbaxy's approvals to launch generic Nexium, Valcyte Ranbaxy Laboratories Ltd has sued the US Food and Drug Administration (FDA) for revoking approvals granted to the firm to......
Shares in AstraZeneca jumped more than 8 per cent in early trading on Tuesday as the Anglo-Swedish pharmaceutical group said it had agreed a long-term deal with Ranbaxy of India to end patent......
A US court has denied a request by drugmaker Ranbaxy Laboratories Ltd to stop competitors from launching copies of AstraZeneca Plc's heartburn pill Nexium and Roche's antiviral Valcyte, a court......